XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income $ 1,004,356 $ 827,706 $ 786,103
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation expense 758,596 707,331 661,578
Amortization of deferred financing costs 7,462 7,454 7,346
Amortization of debt discount 2,681 1,880 1,591
Loss on extinguishment of debt, net 17,787 9,333 602
Amortization of stock-based compensation 25,505 21,603 25,621
Equity (income) in loss of, and return on, unconsolidated entities and noncontrolling interests, net of eliminations (108) 8,673 12,278
Real estate casualty loss 1,723 0 0
Abandonment of development pursuits 685 9,262 2,943
Unrealized gain on terminated cash flow hedges (2,654) (2,894) 0
Cash flow hedge losses reclassified to earnings 7,887 8,984 6,571
Gain on sale of real estate assets (627,637) (346,041) (172,332)
Gain on for-sale condominiums (3,110) (8,213) 0
Increase (decrease) in resident security deposits, prepaid expenses and other assets 5,505 (28,675) (19,118)
Increase in accrued expenses, other liabilities and accrued interest payable 4,492 3,212 8,621
Net cash provided by operating activities 1,203,170 1,219,615 1,321,804
Cash flows from investing activities:      
Development/redevelopment of real estate assets including land acquisitions and deferred development costs (654,861) (843,907) (1,052,011)
Acquisition of real estate assets, including partnership interest (771,692) 0 (420,517)
Capital expenditures - existing real estate assets (142,688) (108,531) (135,626)
Capital expenditures - non-real estate assets (10,547) (28,505) (5,266)
(Decrease) increase in payables for construction (29,887) 1,474 (4,848)
Proceeds from sale of real estate, net of selling costs 850,230 619,773 422,041
Proceeds from the sale of for-sale condominiums, net of selling costs 124,532 202,033 0
Mortgage note receivable lending (1,210) (258) (692)
Mortgage note receivable payments 2,435 3,419 2,779
Distributions from unconsolidated entities 63,171 11,157 10,454
Investments in unconsolidated entities (53,536) (36,088) (10,183)
Net cash used in investing activities (624,053) (179,433) (1,193,869)
Cash flows from financing activities:      
Issuance of common stock, net 31,874 3,464 409,725
Repurchase of common stock, net 0 (183,876) 0
Dividends paid (888,344) (883,212) (839,646)
Issuance of mortgage notes payable 0 51,000 30,250
Repayments of mortgage notes payable, including prepayment penalties (109,562) (126,712) (227,570)
Issuance of unsecured notes 1,098,643 1,296,581 449,804
Repayment of unsecured notes, including prepayment penalties (462,147) (958,680) 0
Payment of deferred financing costs (8,864) (11,277) (10,909)
Receipt (payment) for termination of forward interest rate swaps 4,751 (25,135) (12,309)
Payment to noncontrolling interest (55) (68) 456
Payments related to tax withholding for share-based compensation (13,463) (14,917) (16,101)
Distributions to DownREIT partnership unitholders (48) (48) (46)
Distributions to joint venture and profit-sharing partners (306) (384) (439)
Preferred interest obligation redemption and dividends (1,340) (1,000) (1,400)
Net cash used in financing activities (348,861) (854,264) (218,185)
Net increase (decrease) in cash, cash equivalents and cash in escrow 230,256 185,918 (90,250)
Cash and cash equivalents and restricted cash, beginning of year 313,532 127,614 217,864
Cash and cash equivalents and restricted cash, end of year 543,788 313,532 127,614
Cash paid during the year for interest, net of amount capitalized 203,773 196,848 187,570
Supplemental Cash Flow Information      
Cash and cash equivalents 420,251 216,976 39,687
Cash in escrow 123,537 96,556 87,927
Cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows $ 543,788 $ 313,532 $ 127,614